[1]
Rydholm, A. 2012. Highly different risk estimates for atypical femoral fracture with use of bisphosphonates – debate must be allowed!. Acta Orthopaedica. 83, 4 (Aug. 2012), 319–320. DOI:https://doi.org/10.3109/17453674.2012.718517.